Motoko Shinohara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Motoko Shinohara has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Yusuke Minato
Center for Infectious Disease Research, Fujita Health University
5 shared publications - Yohei Doi
Department of Microbiology, Fujita Health University School of Medicine
3 shared publications - Fumito Maruyama
Microbial Genomics and Ecology, The IDEC Institute, Hiroshima University, Hiroshima, Japan
2 shared publications Kotaro Sawai
Fujita Ika Daigaku
2 shared publications- Yukiko Nishiuchi
Microbial Genomics and Ecology, Center for the Planetary Health and Innovation Science, The IDEC Institute, Hiroshima University, Higashi-Hiroshima, Hiroshima, Japan
2 shared publications - Akiho Yagi
Division of Natural Product Chemistry, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan
1 shared publication
Latest Publications
- Open Access
- 24 June 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (6)
Integrated analysis of transposon insertion sequencing and pangenome reveals core and lineage-specific essential genes in Mycobacterium avium subsp. hominissuis
Pulmonary disease caused by non-tuberculous mycobacteria (NTM-PD) is an emerging global health concern. Among NTM, Mycobacterium avium subsp. hominissuis (MAH) is the major causative agent of NTM-PD. Similar to Mycobacterium tuberculosis , MAH exhibits lineage-specific geographical distributions and host adaptations. Here, we characterized three MAH strains from the residential bathrooms of Mycobacterium avium complex pulmonary disease patients in Japan. A genetic population clustering analysis revealed that the three strains belong to the East Asia (EA) lineages that are predominant in Japan and Korea. Pan-genome analysis using the publicly available complete genome sequences of MAH and the newly sequenced MAH strains identified 3,313 core genes that are conserved among distinct MAH lineages. Identification of essential genes in the three strains was conducted using transposon insertion sequencing, and their gene essentiality profiles were compared to those of a previously studied sequence cluster 3 (SC3) lineage strain, MAC109. Despite their genetic diversity, nearly all essential genes were derived from the core gene set. In addition, we identified a set of common essential genes for the EA and SC3 lineages, as well as lineage-specific essential genes. Our results highlight the evolutionary and clinical importance of lineage-specific adaptations in MAH.
- 24 June 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (6)
Open AccessIntegrated analysis of transposon insertion sequencing and pangenome reveals core and lineage-specific essential genes in Mycobacterium avium subsp. hominissuis
Pulmonary disease caused by non-tuberculous mycobacteria (NTM-PD) is an emerging global health concern. Among NTM, Mycobacterium avium subsp. hominissuis (MAH) is the major causative agent of NTM-PD. Similar to Mycobacterium tuberculosis , MAH exhibits lineage-specific geographical distributions and host adaptations. Here, we characterized three MAH strains from the residential bathrooms of Mycobacterium avium complex pulmonary disease patients in Japan. A genetic population clustering analysis revealed that the three strains belong to the East Asia (EA) lineages that are predominant in Japan and Korea. Pan-genome analysis using the publicly available complete genome sequences of MAH and the newly sequenced MAH strains identified 3,313 core genes that are conserved among distinct MAH lineages. Identification of essential genes in the three strains was conducted using transposon insertion sequencing, and their gene essentiality profiles were compared to those of a previously studied sequence cluster 3 (SC3) lineage strain, MAC109. Despite their genetic diversity, nearly all essential genes were derived from the core gene set. In addition, we identified a set of common essential genes for the EA and SC3 lineages, as well as lineage-specific essential genes. Our results highlight the evolutionary and clinical importance of lineage-specific adaptations in MAH.
- Open Access
- 11 June 2026
- Published by Microbiology Society
- p. 001260.v1
Identification of novel antimicrobial drug combinations with synergistic activity against Mycobacterium abscessus
Mycobacterium abscessus (Mab), classified as a rapid-growing mycobacterium, is naturally resistant to many antimicrobial drugs. Mab infections are typically treated with multidrug therapy, given low efficacy and risk of resistance development with monotherapy. Utilizing effective combinations of antimicrobial drugs with synergistic activity from the early stages of treatment may improve treatment success rates. We conducted a literature search of PubMed to identify studies published between 1992 and 2024 that assessed in vitro antimicrobial drug interactions in Mab. In addition, we evaluated in vitro drug interactions of 15 antimicrobial drugs that are clinically used in Japan. We utilized the diagonal measurement of n-way drug interactions (DiaMOND), a recently developed method to efficiently assess antimicrobial drug interactions. We experimentally identified 17 novel synergistic antimicrobial drug combinations against the standard Mab strain ATCC 19977. However, according to our literature review, only some synergistic interactions were conserved across different Mab strains. Combining a literature review and an in vitro assay, this study presents the most updated landscape of the activity of antimicrobial combinations against Mab.
- 11 June 2026
- Published by Microbiology Society
- p. 001260.v1
Open AccessIdentification of novel antimicrobial drug combinations with synergistic activity against Mycobacterium abscessus
Mycobacterium abscessus (Mab), classified as a rapid-growing mycobacterium, is naturally resistant to many antimicrobial drugs. Mab infections are typically treated with multidrug therapy, given low efficacy and risk of resistance development with monotherapy. Utilizing effective combinations of antimicrobial drugs with synergistic activity from the early stages of treatment may improve treatment success rates. We conducted a literature search of PubMed to identify studies published between 1992 and 2024 that assessed in vitro antimicrobial drug interactions in Mab. In addition, we evaluated in vitro drug interactions of 15 antimicrobial drugs that are clinically used in Japan. We utilized the diagonal measurement of n-way drug interactions (DiaMOND), a recently developed method to efficiently assess antimicrobial drug interactions. We experimentally identified 17 novel synergistic antimicrobial drug combinations against the standard Mab strain ATCC 19977. However, according to our literature review, only some synergistic interactions were conserved across different Mab strains. Combining a literature review and an in vitro assay, this study presents the most updated landscape of the activity of antimicrobial combinations against Mab.
- Open Access
Transposon insertion sequencing identifies genetic determinants of intrinsic rifamycin resistance in Mycobacterium abscessus
Mycobacterium abscessus exhibits intrinsic resistance to many antimicrobial agents, including rifampicin, a frontline anti-tuberculosis drug, severely limiting treatment options. Here, we used transposon insertion sequencing (Tn-Seq) to perform a genomewide screen to identify genes required for intrinsic rifampicin resistance in M. abscessus . We uncovered candidate genes that confer intrinsic resistance to the rifamycin-class antibiotics, rifampicin and rifabutin. The genes we identified included previously reported genes such as arr , helR , and MAB_2807 . By comparing our results with the rifampicin intrinsic resistance gene in Mycobacterium tuberculosis , we found that the mechanisms underlying rifampicin intrinsic resistance were distinct between the two species. The contribution of seven representative candidate genes to rifampicin resistance was confirmed by characterizing targeted gene deletion or transposon insertion mutants. Among these determinants, MAB_2807 was identified as a major efflux-based contributor to rifamycin resistance, and its disruption increased intracellular rifampicin accumulation. In addition to known resistance determinants, Tn-Seq revealed contributions from many genes involved in cell envelope processes to rifamycin resistance. Guided by this genetic signature, we evaluated the combined effects of cell wall-targeting antimicrobial agents with rifamycins. We found that rifamycins displayed selective synergistic interactions with specific β-lactam antibiotics. Interestingly, we found that rifamycin exposure altered cell envelope ultrastructure and increased the accumulation of the peptidoglycan precursor UDP-N-acetylglucosamine, suggesting that rifampicin perturbs envelope-associated metabolic homeostasis. These findings highlight rifamycin-induced vulnerable cellular processes that may inform rational combination strategies.
Open AccessTransposon insertion sequencing identifies genetic determinants of intrinsic rifamycin resistance in Mycobacterium abscessus
Mycobacterium abscessus exhibits intrinsic resistance to many antimicrobial agents, including rifampicin, a frontline anti-tuberculosis drug, severely limiting treatment options. Here, we used transposon insertion sequencing (Tn-Seq) to perform a genomewide screen to identify genes required for intrinsic rifampicin resistance in M. abscessus . We uncovered candidate genes that confer intrinsic resistance to the rifamycin-class antibiotics, rifampicin and rifabutin. The genes we identified included previously reported genes such as arr , helR , and MAB_2807 . By comparing our results with the rifampicin intrinsic resistance gene in Mycobacterium tuberculosis , we found that the mechanisms underlying rifampicin intrinsic resistance were distinct between the two species. The contribution of seven representative candidate genes to rifampicin resistance was confirmed by characterizing targeted gene deletion or transposon insertion mutants. Among these determinants, MAB_2807 was identified as a major efflux-based contributor to rifamycin resistance, and its disruption increased intracellular rifampicin accumulation. In addition to known resistance determinants, Tn-Seq revealed contributions from many genes involved in cell envelope processes to rifamycin resistance. Guided by this genetic signature, we evaluated the combined effects of cell wall-targeting antimicrobial agents with rifamycins. We found that rifamycins displayed selective synergistic interactions with specific β-lactam antibiotics. Interestingly, we found that rifamycin exposure altered cell envelope ultrastructure and increased the accumulation of the peptidoglycan precursor UDP-N-acetylglucosamine, suggesting that rifampicin perturbs envelope-associated metabolic homeostasis. These findings highlight rifamycin-induced vulnerable cellular processes that may inform rational combination strategies.
- Open Access
- 1 April 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (4) , e0166525
Establishment of an in vivo -based assay using a silkworm infection model for phenotypic evaluation of antimicrobial drug combinations against Mycobacterium abscessus
Mycobacterium abscessus exhibits high intrinsic drug resistance, requiring combination therapy. We developed a silkworm ( Bombyx mori ) infection model as a whole-organism, in vivo -based platform for quantitative, outcome-based evaluations of antimicrobial combinations. The system, examined using clarithromycin-amikacin and imipenem-cefoxitin combinations, showed interaction profiles that were qualitatively consistent with those observed in vitro . This rapid, reproducible, and ethical assay enables reliable phenotypic assessments of synergistic or antagonistic effects and may facilitate the evaluation and prioritization of antimicrobial combination regimens in preclinical studies.
- 1 April 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (4) , e0166525
Open AccessEstablishment of an in vivo -based assay using a silkworm infection model for phenotypic evaluation of antimicrobial drug combinations against Mycobacterium abscessus
Mycobacterium abscessus exhibits high intrinsic drug resistance, requiring combination therapy. We developed a silkworm ( Bombyx mori ) infection model as a whole-organism, in vivo -based platform for quantitative, outcome-based evaluations of antimicrobial combinations. The system, examined using clarithromycin-amikacin and imipenem-cefoxitin combinations, showed interaction profiles that were qualitatively consistent with those observed in vitro . This rapid, reproducible, and ethical assay enables reliable phenotypic assessments of synergistic or antagonistic effects and may facilitate the evaluation and prioritization of antimicrobial combination regimens in preclinical studies.
- Open Access
Integrated analysis of Tn-Seq and pangenome reveals core and lineage-specific essential genes in Mycobacterium avium subsp. hominissuis
Pulmonary disease caused by nontuberculous mycobacteria (NTM-PD) is an emerging global health concern. Among NTM, Mycobacterium avium subsp. hominissuis (MAH) is the major causative agent of NTM-PD. Similar to Mycobacterium tuberculosis ( Mtb ), MAH exhibits lineage-specific geographical distributions and host adaptations. Here, we characterized three MAH strains from the residential bathrooms of MAH-PD patients in Japan. A genetic population clustering analysis revealed that the three strains belong to the East Asia (EA) lineages that are predominant in Japan and Korea. Pan-genome analysis using the publicly available complete genome sequences of MAH and the newly sequenced MAH strains identified 3,313 core genes that are conserved among distinct MAH lineages. Identification of essential genes in the three strains was conducted using transposon insertion sequencing (Tn-Seq), and their gene essentiality profiles were compared to those of a previously studied SC3 lineage strain, MAC109. Despite their genetic diversity, nearly all essential genes were derived from the core gene set. In addition, we identified a set of common essential genes for the EA and SC3 lineages, as well as lineage-specific essential genes. Our results highlight the evolutionary and clinical importance of lineage-specific adaptations in MAH. Importance: By integrating transposon insertion sequencing with pan-genome analysis, we provide the first systematic comparison of essential genes across multiple Mycobacterium avium subsp. hominissuis (MAH) strains. Although MAH strains exhibit remarkable genetic diversity, we found that MAH essential genes are primarily confined to the core genome of MAH. This essential plasticity highlights the evolutionary strategies that underpin MAH survival across diverse environments and patient populations. Recognizing this interplay provides a foundation for identifying robust drug targets and developing lineage-informed therapies for MAH infection.
Open AccessIntegrated analysis of Tn-Seq and pangenome reveals core and lineage-specific essential genes in Mycobacterium avium subsp. hominissuis
Pulmonary disease caused by nontuberculous mycobacteria (NTM-PD) is an emerging global health concern. Among NTM, Mycobacterium avium subsp. hominissuis (MAH) is the major causative agent of NTM-PD. Similar to Mycobacterium tuberculosis ( Mtb ), MAH exhibits lineage-specific geographical distributions and host adaptations. Here, we characterized three MAH strains from the residential bathrooms of MAH-PD patients in Japan. A genetic population clustering analysis revealed that the three strains belong to the East Asia (EA) lineages that are predominant in Japan and Korea. Pan-genome analysis using the publicly available complete genome sequences of MAH and the newly sequenced MAH strains identified 3,313 core genes that are conserved among distinct MAH lineages. Identification of essential genes in the three strains was conducted using transposon insertion sequencing (Tn-Seq), and their gene essentiality profiles were compared to those of a previously studied SC3 lineage strain, MAC109. Despite their genetic diversity, nearly all essential genes were derived from the core gene set. In addition, we identified a set of common essential genes for the EA and SC3 lineages, as well as lineage-specific essential genes. Our results highlight the evolutionary and clinical importance of lineage-specific adaptations in MAH. Importance: By integrating transposon insertion sequencing with pan-genome analysis, we provide the first systematic comparison of essential genes across multiple Mycobacterium avium subsp. hominissuis (MAH) strains. Although MAH strains exhibit remarkable genetic diversity, we found that MAH essential genes are primarily confined to the core genome of MAH. This essential plasticity highlights the evolutionary strategies that underpin MAH survival across diverse environments and patient populations. Recognizing this interplay provides a foundation for identifying robust drug targets and developing lineage-informed therapies for MAH infection.
- Open Access
- 20 December 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Synthesis of macrocyclic nucleoside antibacterials and their interactions with MraY
The development of new antibacterial drugs with different mechanisms of action is urgently needed to address antimicrobial resistance. MraY is an essential membrane enzyme required for bacterial cell wall synthesis. Sphaerimicins are naturally occurring macrocyclic nucleoside inhibitors of MraY and are considered a promising target in antibacterial discovery. However, developing sphaerimicins as antibacterials has been challenging due to their complex macrocyclic structures. In this study, we construct their characteristic macrocyclic skeleton via two key reactions. Having then determined the structure of a sphaerimicin analogue bound to MraY, we use a structure-guided approach to design simplified sphaerimicin analogues. These analogues retain potency against MraY and exhibit potent antibacterial activity against Gram-positive bacteria, including clinically isolated drug resistant strains of S. aureus and E. faecium. Our study combines synthetic chemistry, structural biology, and microbiology to provide a platform for the development of MraY inhibitors as antibacterials against drug-resistant bacteria.
- 20 December 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Open AccessSynthesis of macrocyclic nucleoside antibacterials and their interactions with MraY
The development of new antibacterial drugs with different mechanisms of action is urgently needed to address antimicrobial resistance. MraY is an essential membrane enzyme required for bacterial cell wall synthesis. Sphaerimicins are naturally occurring macrocyclic nucleoside inhibitors of MraY and are considered a promising target in antibacterial discovery. However, developing sphaerimicins as antibacterials has been challenging due to their complex macrocyclic structures. In this study, we construct their characteristic macrocyclic skeleton via two key reactions. Having then determined the structure of a sphaerimicin analogue bound to MraY, we use a structure-guided approach to design simplified sphaerimicin analogues. These analogues retain potency against MraY and exhibit potent antibacterial activity against Gram-positive bacteria, including clinically isolated drug resistant strains of S. aureus and E. faecium. Our study combines synthetic chemistry, structural biology, and microbiology to provide a platform for the development of MraY inhibitors as antibacterials against drug-resistant bacteria.